Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
SILVERARC CAPITAL MANAGEMENT LLC | 02-14-2024 | 12-31-2023 | 67 | 335,961,131 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
argenx SE | EQUITIES | 151 | $1,835,955 | 4,826 | 0.00 | 4,826 | +Inf | 12-31-2023 | |
89bio Inc | EQUITIES | 152 | $1,772,891 | 158,719 | 0.00 | 0.00 | 98,472 | 163.45 | 12-31-2023 |
Pmv Pharmaceuticals Inc | EQUITIES | 153 | $1,705,000 | 550,000 | 0.00 | 550,000 | +Inf | 12-31-2023 | |
Altimmune Inc | EQUITIES | 154 | $1,687,500 | 150,000 | 0.00 | 150,000 | +Inf | 12-31-2023 |